Climb Bio Inc (CLYM) Stock Price, Quote, News & History

CLYMNASDAQ
$10.71
-0.78-6.79%
At close: Jun 16, 5:00 PM EST
$10.71
N/A
After Hours: 4:00 PM EST
Loading...

Key Statistics

Open
$11.51
Close
$10.71
Volume / Avg.
864.67K / 848.22K
Day Range
$10.71 - $11.80
52 Wk Range
1.16 - 12.48
Market Cap
$613.29M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
4.71%
Days to Cover
2.82

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-53.30M
Investing Cash Flow (TTM)
32.63M
Financing Cash Flow (TTM)
-16.00K
Free Cash Flow (TTM)
-53.49M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-20.69M

Analyst Trends and Forecast

7
Mar
3
Apr
4
May
4
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$549.44M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
4.45
Earnings Yield % (TTM)
-6.70%
Earnings Yield % (FWD)
-7.39%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.59

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$8.36M
Debt to Equity
0.00
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$11.51
Close
$10.71
Volume / Avg.
864.67K / 848.22K
Day Range
$10.71 - $11.80
52 Wk Range
1.16 - 12.48
Market Cap
$613.29M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
4.71%
Days to Cover
2.82

About

Sector
Health Care
Industry
Biotechnology
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases suc...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Climb Bio (CLYM) stock?

A

You can purchase shares of Climb Bio (NASDAQ:CLYM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Climb Bio (CLYM) competitors?

A

There are no as such competitors for Climb Bio.

Q

What is the forecast, or price target, for Climb Bio (CLYM) stock?

A

Climb Bio has a consensus price target of $20.15.

Q

What is the current price for Climb Bio (CLYM)?

A

The stock price for Climb Bio (NASDAQ: CLYM) is $10.71 last updated June 16, 2026 at 4:00 PM EDT.

Q

Does Climb Bio (CLYM) pay a dividend?

A

There are no upcoming dividends for Climb Bio.

Q

When is Climb Bio (NASDAQ:CLYM) reporting earnings?

A

Climb Bio does not have any upcoming earnings scheduled.

Q

Is Climb Bio (CLYM) going to split?

A

There is no upcoming split for Climb Bio.

Q

What sector and industry does Climb Bio (CLYM) operate in?

A

Climb Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.